inhibit fertility, and they may have negative consequences for the development of the offspring. Oxaliplatin is a platinum-organic drug with antineoplastic properties used for colorectal cancer and cytotoxicity…
Oxaliplatin is a backbone drug of many regimens for colorectal cancer and colorectal liver metastasis. The author previously described a thorough review of the literature on oxaliplatin-induced hepatic complications…
Oxaliplatin is a backbone drug of many regimens for colorectal cancer and colorectal liver metastasis. Most frequent adverse effects in patients with oxaliplatin-based chemotherapy include the peripheral neuropathy…
drug oxaliplatin is important in the chemotherapy of colorectal carcinoma, but its toxicity, especially dose-related neurosensory toxicity, is not well tolerated. We investigated if honokiol could augment the anti…
Oxaliplatin is an essential component of many chemotherapies protocol for colorectal cancer and colorectal liver metastasis. The use of oxaliplatin in patients with colorectal cancer has been associated with…
Background: Oxaliplatin-related hypersensitivity reactions (HSR) are well-known, raising a dilemma for use of critical drug in cancer patients for fear of inducing severe reactions and even fatal, anaphylactic ... been…
inhibit fertility, and may have toxic consequences for the progress of the progeny. Oxaliplatin is a platinum-based anti-cancer drug with antineoplastic properties used mainly for colorectal cancer ... formation of…
synergistic anti-cancer effects in HCT116 human colorectal cancer cells in presence of oxaliplatin, one of the chemotherapeutic agents used to treat colorectal cancer. Methods: HCT116 p53+/+ cell line ... cell sorting…
Oxaliplatin can induce peripheral neuropathy (OXIPN) as an adverse side effect in cancer patients. Until now, no effective, preventive or therapeutic drug has been developed; therefore, the dose-limiting factor…
Oxaliplatin is a platinum-class drug used for advanced colorectal cancer, which is still incurable because ofdrug resistance. We applied a pharmacogenomic approach to correlate mRNA expression profiles of…
Recently the development of Focal Nodular Hyperplasia (FNH)-like lesions after chemotherapy with oxaliplatin or cyclophosphamide in patients with cancers has emerged. Meanwhile, the role of gadoxetic acid ... this…
Oxaliplatin can induce peripheral neuropathy (OXIPN) as an adverse side effect in cancer patients. Until now, no effective preventive or therapeutic drug has been developed; therefore, the dose-limiting factor ... OXIPN…
study was designed to investigate the neuroprotective and anti-nociceptive effects of Ambroxol in oxaliplatin induced neuropathic pain in rats. Administration of oxaliplatin (2.4 mg/kg, i.p.) for 3 weeks ... drop test…
medical history of inflammatory bowel conditions like Crohn's disease or ulcerative colitis. Oxaliplatin, a platinum-based chemotherapy agent, serves as the frontline treatment for colorectal cancer ... instances where…
Chemotherapy-induced peripheral neuropathy (CIPN) is a type of neuropathic pain. Oxaliplatin, a platinum-based chemotherapeutic agent induces peripheral neuropathic pain because of its neuronal toxicities. Therefore…
breast cancers causes cisplatin resistance. In this study, we determined that YB-1 confers oxaliplatin resistance in colorectal adenocarcinomas. We also identify by mass spectrometry analyses important YB-1 interactors…
This study seeks to elucidate the efficacy of oxaliplatin, fluorouracil and calcium folinate combined with hepatic arterial infusion chemotherapy, in patients with advanced primary liver cancer. In this study ... were…
This study contains clinical efficacy of bevacizumab in conjunction with oxaliplatin and capecitabine in managing metastatic colorectal cancer. The study population consisted of 150 individuals diagnosed with metastatic…
Statement of the Problem: Approximately 70% of patients receiving oxaliplatin for colorectal cancer develop painful oxaliplatin- induced peripheral neuropathy (OIPN-P). OIPN-P can persist up to 11 years after ... were…
limit lavishness, and they may have negative repercussions for the progression of the successors. Oxaliplatin is a platinum-characteristic medicine with antineoplastic properties used for colorectal dangerous…
Oxaliplatin is a chemotherapy drug commonly used to treat advanced colorectal cancer and other gastrointestinal malignancies as well as refractory lymphomas. However, it can cause a wide range of adverse ... nausea…
entities. In this article, current knowledge and trends of FNH along with oxaliplatin-induced this entity have been reviewed in detail. Additionally, the author described previously treated two cases ... known that FNH…
Genistein, as chemopreventive agent, has been shown to suppress the growth of several tumors. Oxaliplatin is a chemotherapeutic compound that did show a range of antitumor activity. This research ... carried out to…
simple and reproducible spectrophotometric method was developed for the estimation of cisplatin, carboplatin and oxaliplatin in pure and injectable dosage forms. Method: The method is based on the reaction ... Beer’s…
peripheral blood lymphocytes (PBLs) on the outcome of patients with gastric cancer treated with oxaliplatin-based adjuvant chemotherapy. Tumor and PBL samples from 48 patients treated with adjuvant oxaliplatin-based…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.